{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:58:44Z","timestamp":1790632724728,"version":"4.1.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.exer.2019.107766","type":"journal-article","created":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T18:42:17Z","timestamp":1565980937000},"page":"107766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Angiotensin II and aldosterone in retinal vasculopathy and inflammation"],"prefix":"10.1016","volume":"187","author":[{"given":"Jennifer L.","family":"Wilkinson-Berka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varaporn","family":"Suphapimol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack R.","family":"Jerome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devy","family":"Deliyanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Allingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2019.107766_bib1","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ACE2\/angiotensin 1\u20137 Axis of the renin\u2013angiotensin system in heart failure","volume":"118","author":"Patel","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2019.107766_bib2","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.23.1_supplement.625.3","article-title":"Benzamil decreases microvessel growth in rat aortic rings in vitro","volume":"23","author":"Adair","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.exer.2019.107766_bib3","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1167\/iovs.17-23073","article-title":"Aldosterone exposure causes increased retinal edema and severe retinopathy following laser-induced retinal vein occlusion in mice","volume":"59","author":"Allingham","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107766_bib4","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nm1095-1024","article-title":"Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity","volume":"1","author":"Alon","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.exer.2019.107766_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.visres.2017.06.014","article-title":"Neurodegeneration in diabetic retinopathy: potential for novel therapies","volume":"139","author":"Barber","year":"2017","journal-title":"Vis. Res."},{"key":"10.1016\/j.exer.2019.107766_bib6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.kint.2019.02.030","article-title":"Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis","volume":"96","author":"Barrera-Chimal","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.exer.2019.107766_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100954","article-title":"Combined renin inhibition\/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats","volume":"9","author":"Batenburg","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2019.107766_bib8","first-page":"1450","article-title":"Renin-containing Muller cells of the retina display endocrine features","volume":"36","author":"Berka","year":"1995","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.exer.2019.107766_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.exer.2019.107766_bib10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ncpneph0575","article-title":"The incidence and implications of aldosterone breakthrough","volume":"3","author":"Bomback","year":"2007","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"10.1016\/j.exer.2019.107766_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/CS20110036","article-title":"Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors","volume":"121","author":"Bosnyak","year":"2011","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.exer.2019.107766_bib12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3109\/02713689409047011","article-title":"Renin mRNA is synthesized locally in rat ocular tissues","volume":"13","author":"Brandt","year":"1994","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2019.107766_bib13","first-page":"1848","article-title":"Bevacizumab neutralizes the protective effect of vascular endothelial growth factor on retinal ganglion cells","volume":"16","author":"Brar","year":"2010","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2019.107766_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/bs.vh.2018.09.005","article-title":"Aldosterone and myocardial pathology","volume":"109","author":"Cannavo","year":"2019","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.exer.2019.107766_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0140-6736(97)06209-0","article-title":"Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID study group. EURODIAB controlled trial of lisinopril in insulin-dependent diabetes mellitus","volume":"351","author":"Chaturvedi","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2019.107766_bib16","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S0140-6736(08)61412-9","article-title":"Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials","volume":"372","author":"Chaturvedi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2019.107766_bib17","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.exer.2006.05.009","article-title":"Role of angiotensin II in retinal leukostasis in the diabetic rat","volume":"83","author":"Chen","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2019.107766_bib18","first-page":"1297","article-title":"Prorenin in vitreous and subretinal fluid of the human eye","volume":"10","author":"Danser","year":"1988","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.exer.2019.107766_bib19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1210\/jcem-68-1-160","article-title":"Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy","volume":"68","author":"Danser","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.exer.2019.107766_bib20","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/bjo.2008.156208","article-title":"Promise and potential pitfalls of anti-VEGF drugs in retinopathy of prematurity","volume":"93","author":"Darlow","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107766_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.5.2.2","article-title":"Oral mineralocorticoid-receptor antagonists: real-life experience in clinical subtypes of nonresolving central serous chorioretinopathy with chronic epitheliopathy","volume":"5","author":"Daruich","year":"2016","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.exer.2019.107766_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.preteyeres.2017.10.006","article-title":"Mechanisms of macular edema: beyond the surface","volume":"63","author":"Daruich","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2019.107766_bib23","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1210\/endo-126-3-1673","article-title":"Identification and quantification of renin and prorenin in the bovine eye","volume":"126","author":"Deinum","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.exer.2019.107766_bib24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/HYPERTENSIONAHA.111.188136","article-title":"Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy","volume":"59","author":"Deliyanti","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.exer.2019.107766_bib25","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/ATVBAHA.114.303792","article-title":"Retinal vasculopathy is reduced by dietary salt restriction: involvement of Glia, ENaCalpha, and the renin-angiotensin-aldosterone system","volume":"34","author":"Deliyanti","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.exer.2019.107766_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.visres.2017.05.009","article-title":"The inner blood-retinal barrier: cellular basis and development","volume":"139","author":"Diaz-Coranguez","year":"2017","journal-title":"Vis. Res."},{"key":"10.1016\/j.exer.2019.107766_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuroscience.2009.02.084","article-title":"Neuronal and glial cell expression of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in the rat retina","volume":"161","author":"Downie","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.exer.2019.107766_bib28","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/stem.2848","article-title":"Loss of angiotensin-converting enzyme 2 exacerbates diabetic retinopathy by promoting bone marrow dysfunction","volume":"36","author":"Duan","year":"2018","journal-title":"Stem Cells"},{"key":"10.1016\/j.exer.2019.107766_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93751","article-title":"Diabetic retinopathy: current understanding, mechanisms, and treatment strategies","volume":"2","author":"Duh","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.exer.2019.107766_bib30","series-title":"Diabetes Atlas","author":"Federation","year":"2015"},{"key":"10.1016\/j.exer.2019.107766_bib31","first-page":"876","article-title":"Angiotensin-converting enzyme in bovine, feline, and human ocular tissues","volume":"29","author":"Ferrari-Dileo","year":"1988","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107766_bib32","first-page":"21","article-title":"Angiotensin II binding receptors in retinal and optic nerve head blood vessels. An autoradiographic approach","volume":"32","author":"Ferrari-Dileo","year":"1991","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107766_bib33","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1167\/iovs.12-11427","article-title":"Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2","volume":"54","author":"Foureaux","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107766_bib34","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2165\/00003495-200767120-00008","article-title":"Aliskiren: a review of its use in the management of hypertension","volume":"67","author":"Frampton","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.exer.2019.107766_bib35","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1167\/iovs.17-21546","article-title":"Overexpression of angiotensin-converting enzyme 2 ameliorates amyloid beta-induced inflammatory response in human primary retinal pigment epithelium","volume":"58","author":"Fu","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107766_bib36","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s001250051539","article-title":"Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes","volume":"43","author":"Gilbert","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2019.107766_bib37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/1098-1136(200102)33:2<160::AID-GLIA1015>3.0.CO;2-4","article-title":"Epithelial sodium channel and the mineralocorticoid receptor in cultured rat Muller glial cells","volume":"33","author":"Golestaneh","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.exer.2019.107766_bib38","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1136\/bjo.2006.098582","article-title":"The early treatment for retinopathy of prematurity study: structural findings at age 2 years","volume":"90","author":"Good","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107766_bib39","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.2337\/dc11-0476","article-title":"Benefits of Renin-Angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control","volume":"34","author":"Harindhanavudhi","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.exer.2019.107766_bib40","first-page":"96","article-title":"Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis)","volume":"108","author":"Hartnett","year":"2010","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.exer.2019.107766_bib41","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstrom","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2019.107766_bib42","series-title":"Pediatric Retina","first-page":"39","article-title":"Anatomy and physiology of the retina","author":"Hildebrand GA","year":"2011"},{"key":"10.1016\/j.exer.2019.107766_bib43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jdi.12842","article-title":"(Pro)renin receptor: involvement in diabetic retinopathy and development of molecular targeted therapy","volume":"10","author":"Kanda","year":"2019","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.exer.2019.107766_bib44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.phrs.2017.07.008","article-title":"AT2 receptors in cardiovascular and renal diseases","volume":"125","author":"Kaschina","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.exer.2019.107766_bib45","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1113\/jphysiol.2004.073098","article-title":"Effects of angiotensin II on the pericyte-containing microvasculature of the rat retina","volume":"561","author":"Kawamura","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.exer.2019.107766_bib46","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.survophthal.2018.04.002","article-title":"Retinopathy of prematurity: a review of risk factors and their clinical significance","volume":"63","author":"Kim","year":"2018","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107766_bib47","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1161\/01.CIR.94.10.2566","article-title":"New activity of spironolactone. Inhibition of angiogenesis in vitro and in vivo","volume":"94","author":"Klauber","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.exer.2019.107766_bib48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S0952523800008762","article-title":"Angiotensin II in the rabbit retina","volume":"14","author":"Kohler","year":"1997","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.exer.2019.107766_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.visres.2017.04.003","article-title":"The pathology associated with diabetic retinopathy","volume":"139","author":"Lechner","year":"2017","journal-title":"Vis. Res."},{"key":"10.1016\/j.exer.2019.107766_bib50","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/CIRCRESAHA.109.196576","article-title":"Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors","volume":"105","author":"Lemari\u00e9 Catherine","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2019.107766_bib51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","article-title":"Central serous chorioretinopathy: a review of epidemiology and pathophysiology","volume":"41","author":"Liew","year":"2013","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107766_bib52","first-page":"429","article-title":"Hyperoxia\/normoxia-driven retinal angiogenesis in mice: a role for angiotensin II","volume":"42","author":"Lonchampt","year":"2001","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107766_bib53","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3109\/02713688909000874","article-title":"Angiotensin II receptors labelled with 125I-[Sar1, Ile8]-AII in albino rabbit ocular tissues","volume":"8","author":"Mallorga","year":"1989","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2019.107766_bib54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa0808400","article-title":"Renal and retinal effects of enalapril and losartan in type 1 diabetes","volume":"361","author":"Mauer","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2019.107766_bib55","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ijcard.2012.10.007","article-title":"The past, present and future of renin-angiotensin aldosterone system inhibition","volume":"167","author":"Mentz","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.exer.2019.107766_bib56","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.CIR.0000127112.36796.9B","article-title":"Aldosterone enhances ischemia-induced neovascularization through angiotensin II-dependent pathway","volume":"109","author":"Michel","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.exer.2019.107766_bib57","doi-asserted-by":"crossref","first-page":"F396","DOI":"10.1152\/ajprenal.00576.2009","article-title":"Regulation of the renin expression in the retinal pigment epithelium by systemic stimuli","volume":"299","author":"Milenkovic","year":"2010","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.exer.2019.107766_bib58","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.2337\/db10-0552","article-title":"Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function","volume":"59","author":"Miller","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2019.107766_bib59","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MOP.0b013e32832925f9","article-title":"Antivascular endothelial growth factor for retinopathy of prematurity","volume":"21","author":"Mintz-Hittner","year":"2009","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.exer.2019.107766_bib60","doi-asserted-by":"crossref","first-page":"107680","DOI":"10.1016\/j.exer.2019.05.020","article-title":"The renin angiotensin aldosterone system and its therapeutic targets","volume":"186","author":"Mirabito Colafella","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2019.107766_bib61","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2019.107766_bib62","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11906-014-0431-2","article-title":"Angiotensin II and vascular injury","volume":"16","author":"Montezano","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.exer.2019.107766_bib63","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1161\/01.HYP.36.6.1099","article-title":"Retinal neovascularization is prevented by blockade of the renin-angiotensin system","volume":"36","author":"Moravski","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.exer.2019.107766_bib64","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0002-9440(10)63806-0","article-title":"The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies","volume":"162","author":"Moravski","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2019.107766_bib65","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1006\/bbrc.1999.1834","article-title":"Angiotensin II and retinal pericytes migration","volume":"266","author":"Nadal","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2019.107766_bib66","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1681\/ASN.2009030300","article-title":"The biology of the (Pro)Renin receptor","volume":"21","author":"Nguyen","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.exer.2019.107766_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.240","article-title":"Aldosterone: a mediator of retinal ganglion cell death and the potential role in the pathogenesis in normal-tension glaucoma","volume":"4","author":"Nitta","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.exer.2019.107766_bib68","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.exer.2019.107766_bib69","first-page":"1192","article-title":"Angiotensin II-stimulated vascular endothelial growth factor expression in bovine retinal pericytes","volume":"41","author":"Otani","year":"2000","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107766_bib70","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2019.107766_bib71","first-page":"1","article-title":"Retrolental fibroplasia","volume":"14","author":"Patz","year":"1969","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107766_bib72","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010254","article-title":"The use of a novel non-steroidal mineralocorticoid receptor antagonist finerenone for the treatment of chronic heart failure: a systematic review and meta-analysis","volume":"97","author":"Pei","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.exer.2019.107766_bib73","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1167\/iovs.17-22416","article-title":"The role of angiotensin II\/AT1 receptor signaling in regulating retinal microglial activation","volume":"59","author":"Phipps","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107766_bib74","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.exer.2019.107766_bib75","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2019.107766_bib76","first-page":"1443","article-title":"Expression and cellular localization of the Mas receptor in the adult and developing mouse retina","volume":"20","author":"Prasad","year":"2014","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2019.107766_bib77","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1167\/iovs.14-13883","article-title":"Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice","volume":"55","author":"Qiu","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107766_bib78","first-page":"834","article-title":"Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells","volume":"76","author":"Rautureau","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.exer.2019.107766_bib79","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1161\/HYPERTENSIONAHA.111.180158","article-title":"Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats","volume":"59","author":"Rehman","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.exer.2019.107766_bib80","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00125-016-4115-0","article-title":"The TetO rat as a new translational model for type 2 diabetic retinopathy by inducible insulin receptor knockdown","volume":"60","author":"Reichhart","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2019.107766_bib81","first-page":"676","article-title":"The response of retinal vasculature to angiotensin","volume":"28","author":"Rockwood","year":"1987","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107766_bib82","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bph.13063","article-title":"Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo","volume":"173","author":"Sampson","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exer.2019.107766_bib83","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1167\/iovs.04-0885","article-title":"The renin-angiotensin system and the developing retinal vasculature","volume":"46","author":"Sarlos","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107766_bib84","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.2353\/ajpath.2008.080457","article-title":"(Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system","volume":"173","author":"Satofuka","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2019.107766_bib85","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2337\/db08-0254","article-title":"(Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation","volume":"58","author":"Satofuka","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2019.107766_bib86","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00109-008-0320-8","article-title":"PLZF and the (pro)renin receptor","volume":"86","author":"Schefe","year":"2008","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.exer.2019.107766_bib87","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1167\/iovs.06-1024","article-title":"Angiotensin II and its receptor subtypes in the human retina","volume":"48","author":"Senanayake","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107766_bib88","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10456-016-9526-5","article-title":"Aliskiren decreases oxidative stress and angiogenic markers in retinal pigment epithelium cells","volume":"20","author":"Simao","year":"2017","journal-title":"Angiogenesis"},{"key":"10.1016\/j.exer.2019.107766_bib89","doi-asserted-by":"crossref","first-page":"190724","DOI":"10.1155\/2010\/190724","article-title":"The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy","volume":"2010","author":"Simo","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.exer.2019.107766_bib90","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.phrs.2016.03.018","article-title":"ACE inhibition, ACE2 and angiotensin-(1\u2fff7) axis in kidney and cardiac inflammation and fibrosis","volume":"107","author":"Sim\u00f5es e Silva","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.exer.2019.107766_bib91","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(08)61411-7","article-title":"Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial","volume":"372","author":"Sjolie","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2019.107766_bib92","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1464-5491.2010.03210.x","article-title":"Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme","volume":"28","author":"Sjolie","year":"2011","journal-title":"Diabet. Med."},{"key":"10.1016\/j.exer.2019.107766_bib93","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1097\/HJH.0000000000001438","article-title":"Plasma renin activity to plasma aldosterone concentration ratio correlates with night-time and pulse pressures in essential hypertensive patients treated with angiotensin-converting enzyme inhibitors\/AT1 blockers","volume":"35","author":"Spannella","year":"2017","journal-title":"J. Hypertens."},{"key":"10.1016\/j.exer.2019.107766_bib94","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.exer.2007.06.008","article-title":"Angiotensin II receptor blocker inhibits abnormal accumulation of advanced glycation end products and retinal damage in a rat model of type 2 diabetes","volume":"85","author":"Sugiyama","year":"2007","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2019.107766_bib95","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.exer.2014.03.011","article-title":"Effect of the renin inhibitor aliskiren against retinal ischemia-reperfusion injury","volume":"122","author":"Tenkumo","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2019.107766_bib96","first-page":"1301","article-title":"The anti-inflammatory potential of ACE2\/angiotensin-(1-7)\/mas receptor Axis: evidence from basic and clinical research","volume":"18","author":"Thiago Ruiz Rodrigues","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.exer.2019.107766_bib97","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ejhf.973","article-title":"Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial","volume":"20","author":"Vaduganathan","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.exer.2019.107766_bib98","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/mt.2011.155","article-title":"ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy","volume":"20","author":"Verma","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2019.107766_bib99","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/bjo.80.2.159","article-title":"Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system","volume":"80","author":"Wagner","year":"1996","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107766_bib100","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.ophtha.2018.05.001","article-title":"A dosing study of bevacizumab for retinopathy of prematurity: late recurrences and additional treatments","volume":"125","author":"Wallace","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.107766_bib101","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jnr.21169","article-title":"VEGF-overexpressing transgenic mice show enhanced post-ischemic neurogenesis and neuromigration","volume":"85","author":"Wang","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.exer.2019.107766_bib102","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/0024-3205(79)90013-4","article-title":"Angiotensin I converting enzyme (kininase II) in isolated retinal microvessels","volume":"24","author":"Ward","year":"1979","journal-title":"Life Sci."},{"key":"10.1016\/j.exer.2019.107766_bib103","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1046\/j.1460-9568.1999.00787.x","article-title":"Angiotensin II receptor subtype gene expression and cellular localization in the retina and non-neuronal ocular tissues of the rat","volume":"11","author":"Wheeler-Schilling","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.exer.2019.107766_bib104","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1470320314549791","article-title":"Expression of classical components of the renin-angiotensin system in the human eye","volume":"16","author":"White","year":"2015","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"10.1016\/j.exer.2019.107766_bib105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCRESAHA.108.176008","article-title":"Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology","volume":"104","author":"Wilkinson-Berka","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2019.107766_bib106","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1007\/s00125-011-2239-9","article-title":"Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat","volume":"54","author":"Wilkinson-Berka","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2019.107766_bib107","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.exer.2019.107766_bib108","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1016\/j.febslet.2005.06.058","article-title":"Angiotensin II augments advanced glycation end product-induced pericyte apoptosis through RAGE overexpression","volume":"579","author":"Yamagishi","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.exer.2019.107766_bib109","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/02713680701584123","article-title":"Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy","volume":"32","author":"Zhang","year":"2007","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2019.107766_bib110","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1096\/fj.09-154344","article-title":"The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Muller glial cells","volume":"24","author":"Zhao","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.exer.2019.107766_bib111","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":"Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy","volume":"122","author":"Zhao","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.exer.2019.107766_bib112","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41467-018-08125-6","article-title":"Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration","volume":"10","author":"Zhao","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483519304312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483519304312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:02:43Z","timestamp":1757998963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483519304312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":112,"alternative-id":["S0014483519304312"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2019.107766","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin II and aldosterone in retinal vasculopathy and inflammation","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2019.107766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107766"}}